Gilead Sciences Inc Q2 Adjusted EPS USD -6.75 Vs. IBES Estimate USD -7.24
GILD•Second-quarter results and outlook
Aug. 4 (Reuters) - Gilead Sciences Inc reported second-quarter product sales of $7,627 million.
- Q2 net income: $-10,496 million
- Q2 EPS: $-8.45
- Outlook FY adjusted EPS: $-0.65 to -0.3
- Outlook FY product sales: $30,100-30,400 million
